WO2022158893A3 - 점안 조성물 - Google Patents

점안 조성물 Download PDF

Info

Publication number
WO2022158893A3
WO2022158893A3 PCT/KR2022/001095 KR2022001095W WO2022158893A3 WO 2022158893 A3 WO2022158893 A3 WO 2022158893A3 KR 2022001095 W KR2022001095 W KR 2022001095W WO 2022158893 A3 WO2022158893 A3 WO 2022158893A3
Authority
WO
WIPO (PCT)
Prior art keywords
ophthalmic composition
relates
present
ophthalmic
composition
Prior art date
Application number
PCT/KR2022/001095
Other languages
English (en)
French (fr)
Other versions
WO2022158893A2 (ko
Inventor
이준엽
신윤재
연지선
Original Assignee
주식회사태준제약
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사태준제약 filed Critical 주식회사태준제약
Priority to JP2023544198A priority Critical patent/JP2024504980A/ja
Priority to US18/271,287 priority patent/US20240082188A1/en
Priority to CN202280010772.6A priority patent/CN116801865A/zh
Priority to EP22742869.5A priority patent/EP4282403A2/en
Priority to CA3203779A priority patent/CA3203779A1/en
Publication of WO2022158893A2 publication Critical patent/WO2022158893A2/ko
Publication of WO2022158893A3 publication Critical patent/WO2022158893A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 안정성이 우수한 점안 조성물에 관한 것이다.
PCT/KR2022/001095 2021-01-21 2022-01-21 점안 조성물 WO2022158893A2 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2023544198A JP2024504980A (ja) 2021-01-21 2022-01-21 点眼組成物
US18/271,287 US20240082188A1 (en) 2021-01-21 2022-01-21 Ophthalmic composition
CN202280010772.6A CN116801865A (zh) 2021-01-21 2022-01-21 眼用组合物
EP22742869.5A EP4282403A2 (en) 2021-01-21 2022-01-21 Ophthalmic composition
CA3203779A CA3203779A1 (en) 2021-01-21 2022-01-21 Ophthalmic composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2021-0008925 2021-01-21
KR20210008925 2021-01-21

Publications (2)

Publication Number Publication Date
WO2022158893A2 WO2022158893A2 (ko) 2022-07-28
WO2022158893A3 true WO2022158893A3 (ko) 2023-04-06

Family

ID=82548864

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2022/001095 WO2022158893A2 (ko) 2021-01-21 2022-01-21 점안 조성물

Country Status (7)

Country Link
US (1) US20240082188A1 (ko)
EP (1) EP4282403A2 (ko)
JP (1) JP2024504980A (ko)
KR (2) KR102489633B1 (ko)
CN (1) CN116801865A (ko)
CA (1) CA3203779A1 (ko)
WO (1) WO2022158893A2 (ko)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140045375A (ko) * 2011-05-12 2014-04-16 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 스테로이드 또는 비-스테로이드성 소염제를 갖는 안정한 포비돈-요오드 조성물
KR20150031340A (ko) * 2010-07-15 2015-03-23 코린시언 아프샐믹 인코포레이티드 안과용 약물 전달
KR20190049931A (ko) * 2009-12-15 2019-05-09 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 무자극성 안과용 포비돈-요오드 조성물
KR20190091308A (ko) * 2016-11-29 2019-08-05 오쿨리스 에스에이 안과용 활성 약학 성분 전달을 위한 고형 사이클로덱스트린 복합체의 제조

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4910225B1 (ko) 1969-08-02 1974-03-08
CA1325382C (en) 1988-01-27 1993-12-21 Takahiro Ogawa Locally administrable therapeutic composition for inflammatory disease
JP4910225B2 (ja) 1999-11-09 2012-04-04 東洋紡績株式会社 透明導電性フィルム、及びこれを用いたエレクトロルミネッセンスパネル及びタッチパネル

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190049931A (ko) * 2009-12-15 2019-05-09 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 무자극성 안과용 포비돈-요오드 조성물
KR20150031340A (ko) * 2010-07-15 2015-03-23 코린시언 아프샐믹 인코포레이티드 안과용 약물 전달
KR20140045375A (ko) * 2011-05-12 2014-04-16 포어사이트 바이오쎄라퓨틱스, 인코퍼레이티드 스테로이드 또는 비-스테로이드성 소염제를 갖는 안정한 포비돈-요오드 조성물
KR20190091308A (ko) * 2016-11-29 2019-08-05 오쿨리스 에스에이 안과용 활성 약학 성분 전달을 위한 고형 사이클로덱스트린 복합체의 제조

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MAZET ROSELINE, YAMÉOGO JOSIAS B. G., WOUESSIDJEWE DENIS, CHOISNARD LUC, GÈZE ANNABELLE: "Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation", PHARMACEUTICS, vol. 12, no. 6, 19 June 2020 (2020-06-19), pages 570, XP055856484, DOI: 10.3390/pharmaceutics12060570 *

Also Published As

Publication number Publication date
EP4282403A2 (en) 2023-11-29
JP2024504980A (ja) 2024-02-02
CN116801865A (zh) 2023-09-22
KR102489633B1 (ko) 2023-01-17
KR20230014809A (ko) 2023-01-30
WO2022158893A2 (ko) 2022-07-28
CA3203779A1 (en) 2022-07-28
US20240082188A1 (en) 2024-03-14
KR20220106077A (ko) 2022-07-28

Similar Documents

Publication Publication Date Title
CL2020000594S1 (es) Estuche de auriculares.
WO2019020602A3 (en) LUMINOPHORE AND COMPOSITION
WO2019014395A8 (en) GENERATION OF WATER-SOLUBLE CANNABINOID COMPOUNDS IN PLANT CELL SUSPENSION YEAST AND CROPS AND MATERIAL COMPOSITIONS
AU2018258581A8 (en) RAF-degrading conjugate compounds
WO2018204483A3 (en) Methods for making high intensity sweeteners
WO2017132580A3 (en) Split inteins with exceptional splicing activity
WO2019156717A3 (en) Optically transparent polyimides
AU2020317609A8 (en) Novel heteroaryl-triazole compounds as pesticides
EP4248968A3 (en) Tlr7/8 antagonists and uses thereof
MX2017004617A (es) Variantes estabilizadas de alfa amilasa y su uso.
AU2018293627A1 (en) New azaquinoline derivatives
MX2021008592A (es) Composiciones de trem y usos de las mismas.
MX2022001061A (es) Agentes de interleuquina-2 y usos de los mismos.
MX2022003166A (es) Moduladores de il-17a y usos de los mismos.
WO2019147457A3 (en) Novel polyestermides, processes for the preparation thereof, and polyesteramide compositions
MX2022000632A (es) Cauchos de dieno terminados en carboxi.
GB2568181A (en) Wheat
TWD209956S (zh) 手錶盒
MX2020011986A (es) Composiciones que comprenden glucosa y hemicelulosa y su uso.
WO2020123816A3 (en) Anellosomes and methods of use
MX2021011976A (es) Composiciones de control de artropodos.
WO2020106836A3 (en) Silica alumina composition with improved stability and method for making same
WO2019229536A3 (en) Novel benzodiazepine derivatives and uses thereof
WO2019224548A3 (en) Methods for the production of methacrylates
MX2021015301A (es) Métodos de cultivo celular y composiciones para la producción de anticuerpos.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22742869

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 3203779

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 18271287

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 202280010772.6

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2023544198

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022742869

Country of ref document: EP

Effective date: 20230821